MaxCyte | DEF 14A: Definitive information statements
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Integrated Core Strategies (US) LLC(5.5%),Millennium Management LLC(5.5%), etc.
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Ross Thomas M.
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Sandoval David I.
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Swirsky Douglas J
MaxCyte | 10-K: Annual report
MaxCyte | 8-K: MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
MaxCyte | 8-K: Current report
MaxCyte | 3: Initial statement of beneficial ownership of securities-Officer Sandoval David I.
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
MaxCyte | 144: Notice of proposed sale of securities pursuant to Rule 144
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Casdin Capital, LLC(0%),Casdin Partners Master Fund, L.P.(0%), etc.
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cadian Capital Management, LP(5.5%),Cadian Capital Management GP, LLC(5.5%), etc.
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.09%)
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Integrated Core Strategies (US) LLC(4.8%),Millennium Management LLC(4.8%), etc.
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
MaxCyte | 8-K: Current report
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.0%)
MaxCyte | 8-K: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
No Data